Published in Vaccine Weekly, December 11th, 2002
Under the agreement, Shire will manufacture and supply its Fluviral influenza vaccine to Berna Biotech for sale in international territories excluding Europe and North America. In return, Berna Biotech will manufacture and supply its hepatitis B vaccines, Hepavax Gene and Bio-Hep B and make them available to Shire for exclusive sale in Europe.
Shire Biologics, part of the Shire Group, began its vaccine operations more than a decade ago when it purchased the vaccine operations of the Armand-Frappier Institute, which had...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly